CINECA IRIS Institutional Research Information System

RICCARDO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.337
EU - Europa 1.773
AS - Asia 1.106
SA - Sud America 39
OC - Oceania 25
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.287
IT - Italia 788
CN - Cina 492
SG - Singapore 258
SE - Svezia 157
IE - Irlanda 141
DK - Danimarca 114
FR - Francia 92
GB - Regno Unito 81
DE - Germania 77
JP - Giappone 74
VN - Vietnam 63
FI - Finlandia 47
PL - Polonia 45
AT - Austria 41
KR - Corea 38
CA - Canada 37
HK - Hong Kong 35
ID - Indonesia 35
IN - India 34
UA - Ucraina 34
AU - Australia 25
BE - Belgio 24
NO - Norvegia 21
BR - Brasile 20
ES - Italia 19
NL - Olanda 18
TW - Taiwan 18
GR - Grecia 15
RU - Federazione Russa 15
SN - Senegal 15
TR - Turchia 15
MY - Malesia 13
CH - Svizzera 11
PT - Portogallo 11
UZ - Uzbekistan 9
CU - Cuba 7
AR - Argentina 6
CL - Cile 6
MX - Messico 6
MC - Monaco 5
PH - Filippine 5
CZ - Repubblica Ceca 4
EU - Europa 4
PE - Perù 4
SA - Arabia Saudita 4
SI - Slovenia 4
CO - Colombia 3
NG - Nigeria 3
SD - Sudan 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
LT - Lituania 2
PK - Pakistan 2
RO - Romania 2
SY - Repubblica araba siriana 2
ZA - Sudafrica 2
BG - Bulgaria 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 6.308
Salva come PNG Salva come JPEG
Città #
Chandler 376
Ann Arbor 275
Fairfield 272
Houston 198
Singapore 197
Wilmington 164
Ashburn 161
Torino 160
Beijing 141
Dublin 141
Woodbridge 139
Seattle 131
Turin 123
Cambridge 112
Redwood City 72
Dearborn 64
Santa Clara 64
Pisa 60
Nyköping 58
Shanghai 50
Guangzhou 47
Villeurbanne 43
Jacksonville 42
Milan 41
Columbus 39
Medford 38
Princeton 37
Jakarta 34
Warsaw 33
Fremont 28
Dong Ket 27
Vienna 27
San Diego 23
Nanjing 22
New York 22
Hangzhou 21
Oslo 19
Tokyo 19
Boston 15
Brussels 15
Ottawa 15
Padova 14
Zhengzhou 13
Buffalo 12
Silver Spring 12
Taipei 12
Boardman 11
Erzurum 11
Hong Kong 11
Norwalk 11
Phoenix 11
Rome 11
Athens 10
Changsha 10
Hebei 10
Sydney 10
Tamworth 10
Washington 10
Wuhan 10
Hyderabad 9
Kuala Lumpur 9
Villa Bartolomea 9
Bologna 8
Chengdu 8
Chennai 8
Los Angeles 8
Seoul 8
Vigliano Biellese 8
Duncan 7
La Habana 7
Parma 7
Tianjin 7
Upper Marlboro 7
Bethesda 6
Central District 6
Frankfurt am Main 6
Fuzhou 6
Helsinki 6
Jinan 6
Paris 6
Philadelphia 6
Alicante 5
Gent 5
Hefei 5
Lappeenranta 5
Monza 5
Santiago 5
Strambino 5
Toronto 5
Verona 5
Xian 5
Absecon 4
Apex 4
Chiyoda-ku 4
Columbia 4
Dallas 4
Davis 4
Federal 4
Ithaca 4
Lainate 4
Totale 4.008
Salva come PNG Salva come JPEG
Nome #
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination 586
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 440
Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis 430
Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: Description of the diverse and most represented species 338
The importance of comparative oncology in translational medicine. 335
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA 323
CSPG4: a prototype oncoantigen for translational immunotherapy studies 266
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy 240
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 216
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 213
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 198
The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2+ mammary cancer 196
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. 170
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study 155
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 145
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 141
Novel insights into Notum and glypicans regulation in colorectal cancer 129
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma 129
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 126
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 121
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 103
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 98
A better immune reaction to Erbb-2 96
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. 96
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010–2020) 95
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 93
Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans. 88
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 82
Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy 78
Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences 77
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research 75
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy. 71
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 71
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 65
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma 64
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 64
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 62
Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy 59
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 39
A single cell RNAseq benchmark experiment embedding "controlled" cancer heterogeneity 31
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 28
Canine Melanoma and Osteosarcoma Immunotherapy by Means of In Vivo DNA Electroporation 22
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source 21
Improving Osteosarcoma Treatment: Comparative Oncology in Action 19
OmniReprodubileCellAnalysis: a comprehensive toolbox for the analysis of cellular biology data 13
Totale 6.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.715
article - articoli 0
book - libri 0
conference - conferenze 572
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020785 0 0 0 0 78 149 104 90 123 94 74 73
2020/20211.061 68 65 76 63 78 91 80 68 117 111 98 146
2021/2022896 74 57 54 55 57 65 60 57 55 73 178 111
2022/20231.143 93 90 33 90 124 241 114 78 131 39 67 43
2023/2024604 66 64 51 39 22 79 57 33 5 52 65 71
2024/2025490 34 76 65 123 192 0 0 0 0 0 0 0
Totale 6.507